Recruiting Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia NCT06451770 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +11 more Locations Clinical Study Center — Clearwater, Florida, United States Clinical Study Center — Miami Lakes, Florida, United States Clinical Study Center — Port Orange, Florida, United States Clinical Study Center — New York, United States View all 16 locations View more locations Show fewer locations Loading locations... View Trial Details
